title: t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
authors.forename: Jad J
authors.initials: JJ
authors.lastname: Wakim
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Tirado
authors.forename: Weina
authors.initials: W
authors.lastname: Chen
authors.forename: Robert
authors.initials: R
authors.lastname: Collins
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics; D003937:Diagnosis, Differential; D006801:Humans; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics*; D009536:Niacinamide / Q000031:analogs & derivatives; D015514:Oncogene Proteins, Fusion / Q000235:genetics / Q000502:physiology; D010671:Phenylurea Compounds; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D051562:Proto-Oncogene Proteins c-bcr / Q000235:genetics; D011725:Pyridines / Q000627:therapeutic use*; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics; D000077157:Sorafenib; D014178:Translocation, Genetic
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D015514:Oncogene Proteins, Fusion; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib; C496348:FGFR1 protein, human; D051496:Receptor, Fibroblast Growth Factor, Type 1; C496613:BCR protein, human; D051562:Proto-Oncogene Proteins c-bcr